Astellas Pharma (Germany) Today
| YPH Stock | EUR 9.67 0.03 0.31% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Astellas Pharma is selling for under 9.67 as of the 25th of November 2024; that is 0.31 percent increase since the beginning of the trading day. The stock's last reported lowest price was 9.67. Astellas Pharma has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Astellas Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Moving against Astellas Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Astellas Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Astellas Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Astellas Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Other, Other (View all Sectors) |
Astellas Pharma (YPH) is traded on Munich Exchange in Germany . The company currently falls under 'Large-Cap' category with a current market capitalization of 25.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Astellas Pharma's market, we take the total number of its shares issued and multiply it by Astellas Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Astellas Pharma operates under Other sector and is part of Other industry.
Astellas Pharma generates positive cash flow from operations, but has no cash available
Check Astellas Pharma Probability Of Bankruptcy
Astellas Pharma Risk Profiles
Although Astellas Pharma's alpha and beta are two of the key measurements used to evaluate Astellas Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.6567 | |||
| Standard Deviation | 1.02 | |||
| Variance | 1.03 | |||
| Risk Adjusted Performance | (0.16) |
Astellas Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Astellas Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Additional Tools for Astellas Stock Analysis
When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.